Jaguar Health, Inc. financial data

Symbol
JAGX on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Pine Street Suite 400, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Jaguar Animal Health, Inc. (to 7/31/2017)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 196 % +91.6%
Quick Ratio 52.9 % +68.2%
Return On Equity -325 % +72.2%
Return On Assets -66.8 % +15.1%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 9.9M USD -60.4%
Weighted Average Number of Shares Outstanding, Basic 9.37M shares +2611%
Weighted Average Number of Shares Outstanding, Diluted 9.37M shares +2611%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.11M USD +10.5%
Cost of Revenue 2.09M USD +13%
Research and Development Expense 15.5M USD -20.4%
Selling and Marketing Expense 6.51M USD -2.55%
General and Administrative Expense 16.3M USD +3.18%
Costs and Expenses 40.7M USD -6.93%
Operating Income (Loss) -30.2M USD +8.45%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -38.3M USD +6.12%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -37.7M USD +4.96%
Earnings Per Share, Basic 59.3 USD/shares +95.3%
Earnings Per Share, Diluted 59.3 USD/shares +95.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.3M USD +311%
Accounts Receivable, after Allowance for Credit Loss, Current 1.25M USD -25.4%
Inventory, Net 9.67M USD +15.5%
Assets, Current 36.6M USD +66.1%
Property, Plant and Equipment, Net 476K USD -6.85%
Operating Lease, Right-of-Use Asset 1.06M USD +28.3%
Intangible Assets, Net (Excluding Goodwill) 18.9M USD -9.66%
Assets 58.5M USD +28.8%
Accounts Payable, Current 4.55M USD -11.3%
Accrued Liabilities, Current 3.3M USD +0.27%
Contract with Customer, Liability, Current 170K USD
Liabilities, Current 19.9M USD +59.6%
Contract with Customer, Liability, Noncurrent 595K USD
Operating Lease, Liability, Noncurrent 754K USD +115%
Liabilities 42.9M USD -2.46%
Accumulated Other Comprehensive Income (Loss), Net of Tax -687K USD +13.7%
Retained Earnings (Accumulated Deficit) -337M USD -12.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 13.1M USD +825%
Liabilities and Equity 58.5M USD +28.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.05M USD +29.1%
Net Cash Provided by (Used in) Financing Activities 12.3M USD -34.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares, Issued 25.9M shares -20.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.2M USD -41.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.3M USD +311%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9K USD +50%
Deferred Tax Assets, Valuation Allowance 56.2M USD +97.6%
Deferred Tax Assets, Gross 57.6M USD +98.3%
Operating Lease, Liability 1.12M USD +27.9%
Payments to Acquire Property, Plant, and Equipment 0 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -37.6M USD +7.09%
Lessee, Operating Lease, Liability, to be Paid 1.79M USD +81.5%
Property, Plant and Equipment, Gross 977K USD +1.67%
Operating Lease, Liability, Current 368K USD -30%
Lessee, Operating Lease, Liability, to be Paid, Year Two 233K USD +302%
Lessee, Operating Lease, Liability, to be Paid, Year One 314K USD +3.63%
Operating Lease, Weighted Average Discount Rate, Percent 0.2 pure +17.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 668K USD +513%
Lessee, Operating Lease, Liability, to be Paid, Year Three 238K USD +11800%
Deferred Tax Assets, Operating Loss Carryforwards 51.9M USD +109%
Preferred Stock, Shares Issued 99 shares -70.4%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 77K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 245K USD
Operating Lease, Payments 336K USD +534%
Preferred Stock, Shares Outstanding 99 shares -70.4%
Amortization of Intangible Assets 1.92M USD -1.18%
Depreciation, Depletion and Amortization 501K USD -0.6%
Deferred Tax Assets, Net of Valuation Allowance 1.41M USD +132%
Share-based Payment Arrangement, Expense 1.85M USD -12.2%
Interest Expense 589K USD -93.7%